Exosome Diagnostics has continued on its capital raising roll, bringing in another $17.6 million in financing, and its series B total to $44.7 million. The latest round was funded by Forbion Capital Partners, NGN Capital, Arcus Ventures, Tiger Management and CD Ventures. The company said it would use the money to launch later this year…
Exosome Raises Second Round Funding, Close to Launching Cancer Tests
Exosome Diagnostics has continued on its capital raising roll, bringing in another $17.6 million in financing, and its series B total to $44.7 million. The latest round was funded by Forbion Capital Partners, NGN Capital, Arcus Ventures, Tiger Management and CD Ventures. The company said it would use the money to launch later this year […]